Prognostic value of osteopontin splice variant-c expression in breast cancers: a meta-analysis

Hao, Chengcheng, Wang, Zhiyang, Gu, Yanan, Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111 and Cheng, Shan 2016. Prognostic value of osteopontin splice variant-c expression in breast cancers: a meta-analysis. BioMed Research International 2016 , 7310694. 10.1155/2016/7310694

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

Objectives. Osteopontin (OPN) is overexpressed in breast cancers, while its clinical and prognostic significance remained unclear. This study aimed to assess the prognostic value of OPN, especially its splice variants, in breast cancers. Methods. Data were extracted from eligible studies concerning the OPN and OPN-c expression in breast cancer patients and were used to calculate the association between OPN/OPN-c and survival. Two reviewer teams independently screened the literatures according to the inclusion and exclusion criteria based on quality evaluation. Following the processes of data extraction, assessment, and transformation, meta-analysis was carried out via RevMan 5.3 software. Results. A total of ten studies involving 1,567 patients were included. The results demonstrated that high level OPN indicated a poor outcome in the OS (HR = 2.22, 95% CI: 1.23–4.00, and ; random-effects model) with heterogeneity (%) of breast cancer patients. High level OPN-c appeared to be more significantly associated with poor survival (HR = 2.14, 95% CI: 1.51–3.04, and ; fixed-effects model) with undetected heterogeneity (%). Conclusions. Our analyses indicated that both OPN and OPN-c could be considered as prognostic markers for breast cancers. The high level of OPN-c was suggested to be more reliably associated with poor survival in breast cancer patients.

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Publisher:	Hindawi Publishing Corporation
Funders:	Cancer Research Wales, Cardiff China Medical Scholarship
Date of First Compliant Deposit:	6 July 2016
Date of Acceptance:	8 June 2016
Last Modified:	05 May 2023 00:38
URI:	https://orca.cardiff.ac.uk/id/eprint/92392

Citation Data

Cited 12 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item